<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T17:58:54Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6073227" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6073227</identifier>
        <datestamp>2018-08-13</datestamp>
        <setSpec>ijms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">ijms</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Molecular Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1422-0067</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6073227</article-id>
              <article-id pub-id-type="pmcid">PMC6073227</article-id>
              <article-id pub-id-type="pmc-uid">6073227</article-id>
              <article-id pub-id-type="pmid">29986550</article-id>
              <article-id pub-id-type="doi">10.3390/ijms19071994</article-id>
              <article-id pub-id-type="publisher-id">ijms-19-01994</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Simulated Microgravity Reduces Focal Adhesions and Alters Cytoskeleton and Nuclear Positioning Leading to Enhanced Apoptosis via Suppressing FAK/RhoA-Mediated mTORC1/NF-κB and ERK1/2 Pathways</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhao</surname>
                    <given-names>Tuo</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                  <xref ref-type="author-notes" rid="fn1-ijms-19-01994">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Rong</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-01994">2</xref>
                  <xref ref-type="aff" rid="af3-ijms-19-01994">3</xref>
                  <xref ref-type="author-notes" rid="fn1-ijms-19-01994">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tan</surname>
                    <given-names>Xin</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Jun</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fan</surname>
                    <given-names>Cuihong</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhao</surname>
                    <given-names>Qin</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Deng</surname>
                    <given-names>Yulin</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-19-01994">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Xu</surname>
                    <given-names>Aizhang</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-01994">2</xref>
                  <xref ref-type="aff" rid="af3-ijms-19-01994">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lukong</surname>
                    <given-names>Kiven Erique</given-names>
                  </name>
                  <xref ref-type="aff" rid="af4-ijms-19-01994">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Genth</surname>
                    <given-names>Harald</given-names>
                  </name>
                  <xref ref-type="aff" rid="af5-ijms-19-01994">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Xiang</surname>
                    <given-names>Jim</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-19-01994">2</xref>
                  <xref ref-type="aff" rid="af3-ijms-19-01994">3</xref>
                  <xref rid="c1-ijms-19-01994" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="af1-ijms-19-01994"><label>1</label>School of Life Sciences, Beijing Institute of Technology, Beijing 10081, China; <email>zhaotuobeijing@hotmail.com</email> (T.Z.); <email>tanxing@bit.edu.cn</email> (X.T.); <email>zhangjun@bit.edu.cn</email> (J.Z.); <email>chfan@bit.edu.cn</email> (C.F.); <email>zhaoqin@hotmail.com</email> (Q.Z.); <email>deng@bit.edu.cn</email> (Y.D.)</aff>
              <aff id="af2-ijms-19-01994"><label>2</label>Cancer Research, Saskatchewan Cancer Agency, Saskatoon, SK S7N 4H4, Canada; <email>rol840@mail.usask.ca</email> (R.L.); <email>aix705@mail.usask.ca</email> (A.X.)</aff>
              <aff id="af3-ijms-19-01994"><label>3</label>Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada</aff>
              <aff id="af4-ijms-19-01994"><label>4</label>Department of Biochemistry, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada; <email>Kiven.lukong@usask.ca</email></aff>
              <aff id="af5-ijms-19-01994"><label>5</label>Institute of Toxicology, Hannover Medical School, D-30625 Hannover, Germany; <email>Genth.Harald@mh-hannover.de</email></aff>
              <author-notes>
                <corresp id="c1-ijms-19-01994"><label>*</label>Correspondence: <email>jim.xiang@usask.ca</email>; Tel.: +1-306-966-7039; Fax: +1-306-966-7047</corresp>
                <fn id="fn1-ijms-19-01994">
                  <label>†</label>
                  <p>These authors contribute equally to the work.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>08</day>
                <month>7</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>7</month>
                <year>2018</year>
              </pub-date>
              <volume>19</volume>
              <issue>7</issue>
              <elocation-id>1994</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>6</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>06</day>
                  <month>7</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2018 by the authors.</copyright-statement>
                <copyright-year>2018</copyright-year>
                <license license-type="open-access">
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Simulated-microgravity (SMG) promotes cell-apoptosis. We demonstrated that SMG inhibited cell proliferation/metastasis via FAK/RhoA-regulated mTORC1 pathway. Since mTORC1, NF-κB, and ERK1/2 signaling are important in cell apoptosis, we examined whether SMG-enhanced apoptosis is regulated via these signals controlled by FAK/RhoA in BL6-10 melanoma cells under clinostat-modelled SMG-condition. We show that SMG promotes cell-apoptosis, alters cytoskeleton, reduces focal adhesions (FAs), and suppresses FAK/RhoA signaling. SMG down-regulates expression of mTORC1-related Raptor, pS6K, pEIF4E, pNF-κB, and pNF-κB-regulated Bcl2, and induces relocalization of pNF-κB from the nucleus to the cytoplasm. In addition, SMG also inhibits expression of nuclear envelope proteins (NEPs) lamin-A, emerin, sun1, and nesprin-3, which control nuclear positioning, and suppresses nuclear positioning-regulated pERK1/2 signaling. Moreover, rapamycin, the mTORC1 inhibitor, also enhances apoptosis in cells under 1 g condition via suppressing the mTORC1/NF-κB pathway. Furthermore, the FAK/RhoA activator, toxin cytotoxic necrotizing factor-1 (CNF1), reduces cell apoptosis, restores the cytoskeleton, FAs, NEPs, and nuclear positioning, and converts all of the above SMG-induced changes in molecular signaling in cells under SMG. Therefore, our data demonstrate that SMG reduces FAs and alters the cytoskeleton and nuclear positioning, leading to enhanced cell apoptosis via suppressing the FAK/RhoA-regulated mTORC1/NF-κB and ERK1/2 pathways. The FAK/RhoA regulatory network may, thus, become a new target for the development of novel therapeutics for humans under spaceflight conditions with stressed physiological challenges, and for other human diseases.</p>
              </abstract>
              <kwd-group>
                <kwd>SMG</kwd>
                <kwd>apoptosis</kwd>
                <kwd>focal adhesion complex</kwd>
                <kwd>cytoskeleton</kwd>
                <kwd>nuclear positioning</kwd>
                <kwd>FAK</kwd>
                <kwd>RohA</kwd>
                <kwd>mTORC1</kwd>
                <kwd>NK-κB</kwd>
                <kwd>ERK1/2</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec id="sec1-ijms-19-01994">
              <title>1. Introduction</title>
              <p>The spaceflight environment, containing many physical and psychological stress factors, severely affects human physiology and health [<xref rid="B1-ijms-19-01994" ref-type="bibr">1</xref>]. One of the physiological stress factors is microgravity, which has been demonstrated to promote cell apoptosis [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>,<xref rid="B3-ijms-19-01994" ref-type="bibr">3</xref>,<xref rid="B4-ijms-19-01994" ref-type="bibr">4</xref>]. Apoptosis is a cell-programmed death with characteristics of cell shrinkage, chromatin condensation, nuclear collapse and fragmentations, and cytoplasmic blebbing leading to the formation of apoptotic bodies [<xref rid="B5-ijms-19-01994" ref-type="bibr">5</xref>]. It has been shown that multiple pathways regulate the formation of cell apoptosis, including the mammalian target of rapamycin complex (mTORC), nuclear factor-kappa B (NF-κB), extracellular signal-regulated kinase-1/2 (ERK1/2), and P53/PUMA [<xref rid="B6-ijms-19-01994" ref-type="bibr">6</xref>].</p>
              <p>The cytoskeleton, a cellular structural scaffold, functions in maintaining the cell shape, providing an intracellular transport system, regulating cell migration, and controlling cell survival [<xref rid="B7-ijms-19-01994" ref-type="bibr">7</xref>]. The eukaryotic cytoskeleton is composed of intermediate filaments, actin filaments, and microtubules. Cell surface integrins and intracellular cytoskeleton interact with the extracellular matrix at cellular membrane sites, termed focal adhesions (FAs) [<xref rid="B8-ijms-19-01994" ref-type="bibr">8</xref>]. The integrin-binding molecules, such as talin, vinculin, and paxillin, recruit focal adhesion kinase (FAK) to the site of focal adhesions to form focal adhesion complexes (FACs), which also comprise another group of the ras homolog gene (Rho) family GTPases [<xref rid="B9-ijms-19-01994" ref-type="bibr">9</xref>]. The Rho family members, including Rho family member-A (RhoA), cell division-control protein-42 (Cdc42), and ras-related C3 botulinum-toxin substrate-1 (Rac1), control the function of actin-binding proteins function to form higher-order structures, such as stress fibers (actin/myosin bundles), lamellipodia (membrane ruffles at the leading edge), and filopodia (membrane protrusion) [<xref rid="B10-ijms-19-01994" ref-type="bibr">10</xref>]. In addition, the Rho family members also control some molecular signaling such as the mTORC1 [<xref rid="B11-ijms-19-01994" ref-type="bibr">11</xref>,<xref rid="B12-ijms-19-01994" ref-type="bibr">12</xref>,<xref rid="B13-ijms-19-01994" ref-type="bibr">13</xref>]. Signaling FAK and RhoA have also been found to protect cells from apoptosis and mediate cell survival [<xref rid="B14-ijms-19-01994" ref-type="bibr">14</xref>,<xref rid="B15-ijms-19-01994" ref-type="bibr">15</xref>]. </p>
              <p>Nuclei, though often localized in the center of cells, are sometimes positioned asymmetrically depending upon the status of cell differentiation and migration, as well as the stage of cell cycling [<xref rid="B16-ijms-19-01994" ref-type="bibr">16</xref>]. The molecular toolbox elements controlling nuclear positioning include cytoskeleton and nucleoskeleton, as well as nuclear envelope protein complexes (NEPCs) [<xref rid="B16-ijms-19-01994" ref-type="bibr">16</xref>]. Nuclear positioning has been shown to affect cytoplasmic signaling and influence the nucleus to access signaling pathways, such as RhoA and ERK1/2 pathways [<xref rid="B17-ijms-19-01994" ref-type="bibr">17</xref>,<xref rid="B18-ijms-19-01994" ref-type="bibr">18</xref>].</p>
              <p>Simulated microgravity (SMG), a ground-based method developed to mimic the gravitational conditions that exist in space, was reported to alter cytoskeleton structures [<xref rid="B13-ijms-19-01994" ref-type="bibr">13</xref>,<xref rid="B19-ijms-19-01994" ref-type="bibr">19</xref>,<xref rid="B20-ijms-19-01994" ref-type="bibr">20</xref>,<xref rid="B21-ijms-19-01994" ref-type="bibr">21</xref>] and induce cell apoptosis via up- and down-regulated expression of pro-apoptosis and anti-apoptosis molecules [<xref rid="B3-ijms-19-01994" ref-type="bibr">3</xref>,<xref rid="B4-ijms-19-01994" ref-type="bibr">4</xref>]. We previously applied a random positional machine modeling SMG to investigate SMG’s effect on cell apoptosis and its underlying molecular mechanism [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. We demonstrated that SMG altered cytoskeleton and promoted cell apoptosis through suppressing NF-κB pathway leading to up- and down-regulated pro-apoptosis (caspases 3, 7, 8) and anti-apoptosis (Bcl2 and Bnip3) molecules, respectively [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. However, the up-stream molecules regulating the NF-κB-regulated anti-apoptosis effect in cells under SMG condition is still unclear. We have recently demonstrated that SMG reduced Fas, leading to reduced cell proliferation, invasiveness, and metastasis via inhibition of the FAK/RhoA-regulated mTORC1 pathway [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>].</p>
              <p>In this study, we investigated SMG’s effects on the cytoskeleton structure and formation of FAs. We also examined a potential molecular mechanism regulating the SMG-induced cell apoptosis through studying the cytoskeleton structure, Fas, and expression of signaling molecules in FAs, such as FAK and Rho family proteins (RhoA, Rac1, and Cdc42) and mTORC1 pathway molecules, such as S6 kinase (S6K) and eukaryotic initiation factor-4E (EIF4E) in cells under SMG. In addition, we further assessed SMG’s effect on nuclear positioning through examining the expression of NEPCs in cells under SMG by fluorescence microscopy and Western blotting analyses. We found that SMG reduced FAs and altered the cytoskeleton and nuclear positioning, leading to enhanced cell apoptosis via suppressing FAK/RhoA-controlled mTORC1/NF-κB and ERK1/2 pathways.</p>
            </sec>
            <sec id="sec2-ijms-19-01994">
              <title>2. Results</title>
              <sec id="sec2dot1-ijms-19-01994">
                <title>2.1. Simulated Microgravity Promotes Cell Apoptosis</title>
                <p>Previous reports from our own or other laboratories demonstrated that SMG promotes cell apoptosis [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>,<xref rid="B3-ijms-19-01994" ref-type="bibr">3</xref>,<xref rid="B4-ijms-19-01994" ref-type="bibr">4</xref>]. In this study, we analyzed B16 melanoma BL6-10 cell apoptosis in cells under SMG using an apoptosis kit, and observed apoptotic cells in late stage that were positive for both Annexin V and propidium iodide (PI) (<xref ref-type="fig" rid="ijms-19-01994-f001">Figure 1</xref>). Under SMG (µg) conditions 4.5% the cells were apoptotic, which is significantly more than the 1.7% observed under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f001">Figure 1</xref>), thus indicating that SMG promotes BL6-10 cell apoptosis.</p>
              </sec>
              <sec id="sec2dot2-ijms-19-01994">
                <title>2.2. Simulated Microgravity Alters the Cytoskeleton Structure and Inhibits Expression of F-Actin and F-Actin-Binding Protein</title>
                <p>Morphological changes of the apoptotic cell are mediated by several proteins of the cytoskeleton. Previous reports from our own or other laboratories demonstrated that SMG alters cytoskeleton structures [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>,<xref rid="B13-ijms-19-01994" ref-type="bibr">13</xref>,<xref rid="B19-ijms-19-01994" ref-type="bibr">19</xref>,<xref rid="B20-ijms-19-01994" ref-type="bibr">20</xref>,<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>]. BL6-10 cells growing on the surface of culture chamber slides under 1 g conditions displayed flat and irregular morphology, while they became thick and rounded in shape and aggregated into clusters under SMG (<xref ref-type="fig" rid="ijms-19-01994-f002">Figure 2</xref>A(a,b)), indicating that their cytoskeleton structures may be altered under SMG. To assess the cytoskeleton alteration triggered by SMG, we stained cells with FITC-labeled phalloidin for the measurement of microfilaments. Cells under 1 g conditions showed an even distribution of staining, abundant lamellipodia, stress fibers, and filopodia, while cells under SMG showed a dramatic decrease in lamellipodia and stress fibers (<xref ref-type="fig" rid="ijms-19-01994-f002">Figure 2</xref>A(c,d)), which is consistent with our previous report [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. These data further validate that SMG alters the cytoskeleton structure. F-actin filamin-A and F-actin-binding proteins (ABPs) such as TM1, are key components of actin filaments, and have been found to regulate cell apoptosis [<xref rid="B23-ijms-19-01994" ref-type="bibr">23</xref>]. We, therefore, assessed the effect of SMG on the expression of ABPs by Western blotting analysis using anti-filamin-A and anti-TM1 antibodies. We observed that expression levels of filamin-A and TM1 were down-regulated and up-regulated, respectively, in cells under SMG than that in cells under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f002">Figure 2</xref>B), suggesting that these molecules may play a role in SMG-mediated cytoskeletal changes.</p>
              </sec>
              <sec id="sec2dot3-ijms-19-01994">
                <title>2.3. Simulated Microgravity Reduces Focal Adhesions and Inhibits FAK and RhoA Signaling</title>
                <p>Since integrin-binding proteins, which recruit FAK to focal adhesions, are a part of cellular FAs [<xref rid="B9-ijms-19-01994" ref-type="bibr">9</xref>], we investigated the effect of SMG on the integrity of integrin-binding proteins. We stained cells grown on slides coated with integrin ligand fibronectin under SMG with anti-integrin-binding protein paxillin antibody, followed by examination of the cells by fluorescence microscopy to assess the formation of cell FAs. We found that the total number of FAs was substantially reduced in cells under SMG in comparison with control cells under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f003">Figure 3</xref>A). These data indicate that SMG dramatically reduces formation of cellular focal adhesions. FAK is a cytoplasmic tyrosine kinase involved in integrin-mediated signaling and colocalizes with integrins in focal contacts. FAK activation (indicated by phosphorylation at Tyr 397) has been shown to regulate integrins binding to their extracellular ligands. We, therefore, assessed the effect of SMG on FAK activity. We performed Western blotting analysis using cell lysates and anti-FAK and anti-pFAK (Y397) antibodies. We found that the active form of FAK, FAK pY397, was significantly reduced in cells under SMG (1µg), though its FAK expression maintained at the same level as cells under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f003">Figure 3</xref>B). Rho family molecules, including RhoA, Rac1, and Cdc42, are key regulators of cellular morphogenesis and cell polarity mainly through their effects on the cytoskeleton. To determine any functional link between SMG and Rho family molecules, we assessed the effect of SMG on the expression of Rho family proteins by Western blotting analysis using antibodies against RhoA, Rac1, and Cdc42. We showed that SMG induces the down-regulation of RhoA, Rac1, and Cdc42 (<xref ref-type="fig" rid="ijms-19-01994-f003">Figure 3</xref>B). We further assessed the effect of SMG on RhoA activity, using a G-LISA RhoA Activation Assay Biochem kit. We observed that RhoA activity was significantly reduced in SMG-treated cells compared to that in cells under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f003">Figure 3</xref>C). Together, our data indicate that SMG promotes the inhibition of both FAK and RhoA signaling events.</p>
              </sec>
              <sec id="sec2dot4-ijms-19-01994">
                <title>2.4. Simulated Microgravity Suppresses the mTORC/NF-κB Pathway</title>
                <p>Since RhoA regulates the conserved signaling the mTORC1 pathway [<xref rid="B11-ijms-19-01994" ref-type="bibr">11</xref>,<xref rid="B24-ijms-19-01994" ref-type="bibr">24</xref>], we then investigated whether SMG affects the mTORC pathway by assessing the expression of mTORC1-comprising molecule Raptor and mTORC1-regulated molecules, such as S6K and EIF4E [<xref rid="B25-ijms-19-01994" ref-type="bibr">25</xref>], as well as mTORC2-comprising molecule Rictor. Interestingly, we found that SMG suppressed the expression of Raptor, pS6K (S235), and Rictor (<xref ref-type="fig" rid="ijms-19-01994-f004">Figure 4</xref>A). Since the mTORC1 regulates NF-κB-mediated cell apoptosis via up-regulation of anti-apoptosis Bcl2 molecule [<xref rid="B26-ijms-19-01994" ref-type="bibr">26</xref>], we also assessed the expression of these molecules in cells under SMG. We found that SMG down-regulated expression of pNF-κB (S337) and Bcl2 (<xref ref-type="fig" rid="ijms-19-01994-f004">Figure 4</xref>B), and switched cellular localization of FITC-pNF-κB (S337) (green) from the nucleus (DAPI, blue) to the cytoplasm in cells under SMG by confocal microscopic analysis (<xref ref-type="fig" rid="ijms-19-01994-f004">Figure 4</xref>C).</p>
              </sec>
              <sec id="sec2dot5-ijms-19-01994">
                <title>2.5. Rapamycin Inhibits the mTORC1/NF-κB Pathway Leading to Enhanced Apoptosis in Cells under 1 g Conditions</title>
                <p>Since rapamycin inhibits the mTORC1/NF-κB pathway [<xref rid="B26-ijms-19-01994" ref-type="bibr">26</xref>,<xref rid="B27-ijms-19-01994" ref-type="bibr">27</xref>], we performed experiments to assess whether rapamycin mimics the effect of SMG on the promotion of cell apoptosis via suppression of the mTORC1/NF-κB pathway. We found that administration of rapamycin inhibited pS6K (S235) and pNF-κB (S337) (<xref ref-type="fig" rid="ijms-19-01994-f005">Figure 5</xref>A), switched the cellular localization of FITC-pNF-κB (S337) (green) from the nucleus (DAPI, blue) to the cytoplasm (<xref ref-type="fig" rid="ijms-19-01994-f005">Figure 5</xref>B), and increased apoptosis in cells under 1 g conditions (<xref ref-type="fig" rid="ijms-19-01994-f005">Figure 5</xref>C), thus confirming that SMG-induced inhibition of the mTORC1/NF-κB pathway promotes cell apoptosis.</p>
              </sec>
              <sec id="sec2dot6-ijms-19-01994">
                <title>2.6. Simulated Microgravity Reduces Nuclear Positioning and Down-Regulated ERK1/2 Pathway</title>
                <p>As mentioned earlier, nuclear positioning has been shown to be regulated by various factors, including the cytoskeleton and nucleoskeleton and nuclear envelope protein complexes [<xref rid="B16-ijms-19-01994" ref-type="bibr">16</xref>]. Therefore, to assess whether SMG affects nuclear positioning, we examined nuclear envelop proteins (NEPs) by fluorescence microscopy and Western blotting analyses. We demonstrated that SMG significantly reduced the expression of NEPs (lamin A, emerin, sun1, and nesprin3) on the nuclear membrane by fluorescence microscopy (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>A) and in the cell lysates by Western blotting (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>B), compared to those in cells under the 1 g condition. Our data indicate that SMG alters nuclear positioning via down-regulation expression of NEPs. Since nuclear positioning has been shown to affect ERK1/2 signaling [<xref rid="B17-ijms-19-01994" ref-type="bibr">17</xref>,<xref rid="B28-ijms-19-01994" ref-type="bibr">28</xref>,<xref rid="B29-ijms-19-01994" ref-type="bibr">29</xref>,<xref rid="B30-ijms-19-01994" ref-type="bibr">30</xref>], we assessed whether SMG affects ERK1/2 signaling in cells under SMG. We showed that SMG significantly inhibited phosphorylation of ERK1/2 (T202/Y204) under SMG compared to the control 1 g condition (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>C).</p>
              </sec>
              <sec id="sec2dot7-ijms-19-01994">
                <title>2.7. CNF1 Restores SMG-Induced Cellular Morphology and Molecular Signaling Events</title>
                <p>Since toxin CNF1 from <italic>Escherichia coli</italic> has been found to increase cell focal adhesions via activation of FAK [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>] and to activate Rho family members (RhoA, Rac1, and Cdc42) [<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-01994" ref-type="bibr">32</xref>], we assessed whether CNF1 is able to rescue the observed SMG-induced effects on cellular morphology and molecular signaling. Interestingly, our experiments did show that CNF1 (i) restored focal adhesions (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>A); (ii) enhanced FAK/RhoA signaling (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>B) and RhoA activity (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>C); (iii) activated the mTORC1/NF-κB pathway by up-regulation of mTORC-comprising Raptor and Rictor and mTORC1-regulated pS6K (S235), and pNF-κB (S337) and pNF-κB-regulated Bcl2 (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>B); and (iv) switched cellular localization of FITC-pNF-κB (S337) (green) from the cytoplasm to the nucleus (DAPI, blue) (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>D) in cells under SMG. In addition, CNF1 also (i) restored the formation of NEPCs (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>A); (ii) up-regulated the expression of NEPs (lamin-A, emerin, sun1, and nesprin-3) (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>B); and (iii) activated the ERK1/2 pathway in cells under SMG (<xref ref-type="fig" rid="ijms-19-01994-f006">Figure 6</xref>C). Finally, we performed experiments to assess whether CNF1 affects SMG-enhanced cell apoptosis, and found that administration of CNF1 significantly reduced SMG-enhanced apoptosis in cells under SMG (<xref ref-type="fig" rid="ijms-19-01994-f007">Figure 7</xref>E). Together, our data shows that CNF1 restores focal adhesions and NEPCs and activates FAK/RhoA, mTORC1/NF-κB, and ERK1/2 pathways, leading to reduced apoptosis in cells under SMG. </p>
              </sec>
            </sec>
            <sec id="sec3-ijms-19-01994">
              <title>3. Discussion</title>
              <p>Studies showed that SMG altered tumor cell cytoskeleton structure [<xref rid="B13-ijms-19-01994" ref-type="bibr">13</xref>,<xref rid="B19-ijms-19-01994" ref-type="bibr">19</xref>,<xref rid="B20-ijms-19-01994" ref-type="bibr">20</xref>]. However, its molecular mechanism is not well known. In this study, we investigated the effect of SMG on the alteration of BL6-10 cell cytoskeleton structure. We demonstrate that SMG alters the cell cytoskeleton by losing most stress fibers and lamellipodia, consistent with our previous report [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. To assess the formation of cell focal adhesions, we stained the cells on chamber slides cultured under 1 g or µg conditions with an antibody against paxillin (a focal adhesion-associated adaptor protein), followed by observation under a fluorescein microscope. Interestingly, we find that SMG significantly reduces the formation of cell focal adhesions leading to the inhibition of the FAK/RhoA pathway, the critical molecular signal controlling the cytoskeleton [<xref rid="B10-ijms-19-01994" ref-type="bibr">10</xref>], and inhibits the mTORC2 pathway regulating the cytoskeleton structure via controlling RhoA [<xref rid="B33-ijms-19-01994" ref-type="bibr">33</xref>,<xref rid="B34-ijms-19-01994" ref-type="bibr">34</xref>,<xref rid="B35-ijms-19-01994" ref-type="bibr">35</xref>,<xref rid="B36-ijms-19-01994" ref-type="bibr">36</xref>]. Our data, thus, clearly indicates that SMG-induced cytoskeletal alterations result from SMG-inhibited FAK-regulated RhoA as well as SMG-inhibited PI3K-regulated mTORC2 [<xref rid="B37-ijms-19-01994" ref-type="bibr">37</xref>]. </p>
              <p>Successful cell apoptosis is coordinated by caspases, a family of cysteine proteases, cleaving cell proteins by targeting aspirate residues [<xref rid="B38-ijms-19-01994" ref-type="bibr">38</xref>]. Two major pathways were associated with cell apoptosis, the intrinsic pathway and the extrinsic pathway, which activate the apoptosis initiators caspases 8 and 9 [<xref rid="B39-ijms-19-01994" ref-type="bibr">39</xref>], the former induced by cell stresses is regulated by Bcl-2 family members, such as anti- and pro-apoptotic molecules, while the latter was induced by the ligation of extracellular “death” molecules, such as TNF-α or Fas, with their cognate membrane receptors (TNFR and FasL) [<xref rid="B40-ijms-19-01994" ref-type="bibr">40</xref>]. SMG was reported to induce cell apoptosis via up- and down-regulated expression of pro-apoptosis and anti-apoptosis molecules [<xref rid="B3-ijms-19-01994" ref-type="bibr">3</xref>,<xref rid="B4-ijms-19-01994" ref-type="bibr">4</xref>]. We previously showed that SMG promoted cell apoptosis through suppressing the NF-κB pathway, leading to up- and down-regulated pro-apoptosis (caspases 3, 7, 8) and anti-apoptosis (Bcl2 and Bnip3) molecules [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. However, the up-stream molecules regulating the NF-κB-regulated anti-apoptosis effect in cells under SMG condition is still unclear.</p>
              <p>Multiple pathways regulate the formation of cell apoptosis, including mTORC, NF-κB, and ERK1/2 [<xref rid="B6-ijms-19-01994" ref-type="bibr">6</xref>]. SMG was reported to inhibit cell focal adhesions [<xref rid="B19-ijms-19-01994" ref-type="bibr">19</xref>]. However, the significance of SMG-induced inhibition of focal adhesions was not elucidated. We have recently demonstrated that SMG reduced focal adhesions leading to the inhibition of the FAK/RhoA and mTORC1 pathways [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>]. In this study, we confirm our above findings that SMG inhibits the formation of focal adhesions and suppresses the FAK and FAK-regulated RhoA family member (RhoA, Rac1, and Cdc42) signaling, as well as suppresses the RhoA-controlled mTORC1 (S6K and EIF4E) pathway. It has been reported that mTORC1 regulates NF-κB controlling cell apoptosis via up-regulation of the anti-apoptosis Bcl2 molecule [<xref rid="B26-ijms-19-01994" ref-type="bibr">26</xref>], while SMG inhibits the NF-κB pathway [<xref rid="B41-ijms-19-01994" ref-type="bibr">41</xref>]. We assume that SMG-induced apoptosis may be derived from the SMG-inhibited FAK/RhoA-regulated mTORC1/NF-κB pathway. To address this assumption, we assessed the expression of the mTORC1/NF-κB pathway-related molecules in cells under SMG. We demonstrate that SMG down-regulates expression of not only the mTORC1 pathway-related pS6K (S235) and pEIF4E (S209), but also the NF-κB pathway-related pNF-κB (S337) and Bcl2. In addition, SMG also switches cellular localization of pNF-κB (S337) from the nucleus to the cytoplasm. Furthermore, we demonstrate that rapamycin, the inhibitor of mTORC1, also promotes apoptosis via down-regulation of the mTORC1/NF-κB pathway in cells under 1 g conditions. Taken together, our data indicate that SMG promotes cell apoptosis via down-regulation of the mTORC1/NF-κB pathway.</p>
              <p>To confirm the above findings, we performed SMG studies using CNF1, a broad-spectrum activator of FAK and Rho proteins [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>,<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-01994" ref-type="bibr">32</xref>]. In this study, we demonstrate that the CNF1 toxin reduces apoptosis in cells under SMG. We also show that CNF1 activates the upstream signaling (FAK and RhoA) of the mTORC1 pathway and is capable of converting the SMG-induced reduction of cell focal adhesions and SMG-induced FAK/RhoA-regulated inhibition of the mTORC1/NF-κB pathway. Therefore, our data confirm that SMG reduces focal adhesions, leading to enhanced cell apoptosis via suppressing the FAK/RhoA-regulated mTORC1/NF-κB pathway (<xref ref-type="fig" rid="ijms-19-01994-f008">Figure 8</xref>).</p>
              <p>The nuclear envelope is a double-layer membrane separating nuclear chromatin from the cytoplasm, thereby conferring regulation of gene expression and DNA replication [<xref rid="B42-ijms-19-01994" ref-type="bibr">42</xref>]. The outer nuclear membrane (ONM) is contiguous with the cytoplasmic reticulum, while the inner nuclear membrane (INM) contains unique integral NEPs (such as sun1, emerin, lamin A) linking a network of nuclear lamins, called the nucleoskeleton (intermediate filaments), that underlies the INM in the nucleoplasm, and links the cytoskeleton in the cytoplasm through the nuclear envelope connectors (such as nesprins) [<xref rid="B16-ijms-19-01994" ref-type="bibr">16</xref>]. NEPs that comprise both nuclear envelope proteins and connectors play an important role in the regulation of nuclear positioning, which affects cytoplasmic signaling pathways [<xref rid="B17-ijms-19-01994" ref-type="bibr">17</xref>,<xref rid="B18-ijms-19-01994" ref-type="bibr">18</xref>,<xref rid="B28-ijms-19-01994" ref-type="bibr">28</xref>,<xref rid="B29-ijms-19-01994" ref-type="bibr">29</xref>,<xref rid="B43-ijms-19-01994" ref-type="bibr">43</xref>,<xref rid="B44-ijms-19-01994" ref-type="bibr">44</xref>]. In this study, we, for the first time, demonstrate that SMG inhibits the expression of NEPs (sun1, emerin, lamin A, and nesprins), and alters nuclear positioning. It has been demonstrated that FAK controls cell survival and mediates cell apoptosis via the ERK1/2 signaling pathway [<xref rid="B14-ijms-19-01994" ref-type="bibr">14</xref>], and alteration of nuclear positioning also regulates ERK1/2 [<xref rid="B16-ijms-19-01994" ref-type="bibr">16</xref>]. In this study, we assessed whether SMG reduced FAK activity and altered nuclear positioning affected ERK1/2 signaling. Our experiments show that SMG reduces the phosphorylation of ERK1/2 (T202/Y204). Therefore, our data indicate that SMG reduces focal adhesions and promotes cell apoptosis via down-regulation of NEPs and alteration of nuclear positioning leading to down-regulation of the ERK1/2 pathway.</p>
              <p>The cytoskeleton alteration has been reported to induce cell apoptosis [<xref rid="B45-ijms-19-01994" ref-type="bibr">45</xref>]. Especially, the dynamics of actin and the expression of ABPs (such as down- and up-regulation of F-actin filamin-A and ABP TM1) directly affecting mitochondrial membrane permeabilization and caspase activation make a significant contribution to apoptosis [<xref rid="B23-ijms-19-01994" ref-type="bibr">23</xref>]. The mTORC2 signaling has been reported to alter the cytoskeleton structure via suppressing Rho GTPases with a regulatory effect on the expression of ABPs [<xref rid="B30-ijms-19-01994" ref-type="bibr">30</xref>]. In this study, we also assessed whether SMG affects the expression of ABP TM1 [<xref rid="B46-ijms-19-01994" ref-type="bibr">46</xref>] and F-actin filamin-A [<xref rid="B47-ijms-19-01994" ref-type="bibr">47</xref>], and whether SMG affects the mTORC2 pathway. We demonstrate that SMG down- and up-regulates the expression of F-actin filamin-A and ABP TM1, respectively, which is consistent with its promotion of apoptosis [<xref rid="B23-ijms-19-01994" ref-type="bibr">23</xref>], and suppresses the mTORC2 pathway in cells under SMG, indicating that SMG promotes cell apoptosis via altered cytoskeleton-induced alteration of actin dynamics and the suppression of the PI3K-regulated mTORC2 pathway. </p>
              <p>To confirm the above findings, we performed SMG studies using the FAK/RhoA activator CNF1 [<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-01994" ref-type="bibr">32</xref>] in cells under SMG. We demonstrate that administration of CNF1 not only restores SMG-altered nuclear positioning by up-regulation of NEPs and SMG-inhibited ERK1/2 pathway, but also restores SMG-altered actin dynamics by down-regulation of ABP TM1 and up-regulation of the actin filamin-A, and that SMG inhibited the mTORC2 pathway in cells. Therefore, our data confirm that SMG alters the cytoskeleton and nuclear positioning leading to enhanced apoptosis via suppressing the FAK/RhoA-regulated ERK1/2 and mTORC2 pathways (<xref ref-type="fig" rid="ijms-19-01994-f008">Figure 8</xref>).</p>
              <p>The aerospace microgravity has been demonstrated to inhibit tumor cell proliferation and metastasis [<xref rid="B48-ijms-19-01994" ref-type="bibr">48</xref>], promote cell apoptosis [<xref rid="B3-ijms-19-01994" ref-type="bibr">3</xref>,<xref rid="B4-ijms-19-01994" ref-type="bibr">4</xref>], and suppress osteoblastic differentiation and mineralization leading to bone loss [<xref rid="B49-ijms-19-01994" ref-type="bibr">49</xref>]. However, the underlying mechanisms for these observations are not clearly understood. We, for the first time, have demonstrated that SMG significantly inhibits cell focal adhesions and FAK/RhoA activity, and elucidated that SMG reduces tumor cell proliferation and metastasis via suppressing the FAK/RhoA-controlled mTORC1 pathway [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>]. In this study, we further demonstrate that SMG also promotes cell apoptosis through abrogation of cell focal adhesions leading to the suppression of FAK/RhoA-controlled mTORC1/NF-κB and ERK1/2 pathways. We, therefore, assume that the FAK/RhoA regulatory network may be important in other SMG-induced physiological alterations, such as SMG-induced bone loss [<xref rid="B49-ijms-19-01994" ref-type="bibr">49</xref>], often seen in rheumatoid arthritis [<xref rid="B50-ijms-19-01994" ref-type="bibr">50</xref>]. To assess this assumption, we are currently conducting similar SMG experiments using the MC3T3 pre-osteoblast cell line [<xref rid="B49-ijms-19-01994" ref-type="bibr">49</xref>] in our laboratory.</p>
              <p>Taken together, our data reveal a new molecular mechanism for SMG-related studies, that SMG reduces focal adhesion complexes and alters the cytoskeleton and nuclear positioning leading to enhanced cell apoptosis via suppressing FAK/RhoA-regulated mTORC1/NF-κB and ERK1/2 pathways. Thus, the FAK/RhoA regulatory network may become an important target for development of new therapeutics for humans under the spaceflight environment with stressed physiological challenges and for other human diseases. </p>
            </sec>
            <sec id="sec4-ijms-19-01994">
              <title>4. Materials and Methods</title>
              <sec id="sec4dot1-ijms-19-01994">
                <title>4.1. Cells, Antibodies, and Reagents</title>
                <p>BL6-10, which is a highly lung-metastatic B16 melanoma cell line [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>], and showed enhanced cell apoptosis under SMG [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>], was maintained in α-MEM medium supplemented with 10% fetal calf serum (FCS). Rabbit antibodies against Raptor and Rictor were purchased from Thermo Fisher Scientific (Rockford, IL, USA). Rabbit antibodies against RhoA and Rac1 were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Rabbit antibodies against Cdc42, FAK, phosphor-FAK (pFAK; Y397), pS6K (S235), pERK1/2 (T202/Y204), pNF-κB (S337), and Bcl2 were obtained from Cell Signaling Technology (Boston, MA, USA). Rabbit antibodies against paxillin, vinculin, lamin-A, emerin, sun1, filament-A, nesprin-3, and tropomyosin-1 (TM1) were obtained from Abcam Inc. (Cambridge, MA, USA). FITC-labeled phalloidin was purchased from Sigma-Aldrich (St. Louis, MO, USA). FITC-Annexin V Apoptosis Detection kit II was purchased from BD Pharmingen™ (Toronto, ON, Canada). Toxin cytotoxic necrotizing factor-1 (CNF1), which activates both FAK and RhoA [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>,<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-01994" ref-type="bibr">32</xref>], was obtained from Harald Genth, Hannover Medical School, Hannover, Germany [<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>]. FITC-conjugated goat anti-rabbit (ZF-0314) secondary antibody specific for primary antibodies were purchased from ZSGB-Bio Inc. (Beijing, China). The Prolong1gold Antifade Reagent with DAPI was obtained from Life technologies Inc. (Carlsbad, CA, USA). The mTORC inhibitor rapamycin was purchased from SelleckchemInc (Houston, TX, USA).</p>
              </sec>
              <sec id="sec4dot2-ijms-19-01994">
                <title>4.2. Clinostat of Simulated Microgravity</title>
                <p>The SMG environment [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>,<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>] is modeled by the random positional machine (RPM), which is a three-dimensional clinostat manufactured by the Center for Space Science and Applied Research, Chinese Academy of Sciences (Beijing, China). The RPM consists of two independent rotating frames, an inner frame and an outer frame. Both frames can rotate randomly in three-dimensions with changes in the acceleration and direction of the samples over time, resulting in randomization of the gravitational vector, low fluid shear stress, and three-dimensional spatial freedom. The angular velocity of the rotation is at a speed of 30°/s. To examine the gravitational effect, BL6-10 tumor cells were transferred into T25 culture flasks or chamber culture slides (Nalge Nunc International Inc., Rochester, NY, USA), and grown for 24 h, allowing cell to attach to the culture flasks or chamber slides. Cells were then cultured for one to two days at 37 °C in a CO<sub>2</sub> incubator under ground conditions (1 g) or on the clinostat under SMG conditions (µg) with the chambers or flasks filled up with 37 °C warm culture medium [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. To assess the effect of CNF1, we added CNF1 (30 ng/mL) to BL6-10 cells [<xref rid="B31-ijms-19-01994" ref-type="bibr">31</xref>,<xref rid="B32-ijms-19-01994" ref-type="bibr">32</xref>] under SMG.</p>
              </sec>
              <sec id="sec4dot3-ijms-19-01994">
                <title>4.3. Fluorescent Microscopy</title>
                <p>For microtubule immunofluorescence staining, after removing the medium, BL6-10 cells were washed twice with PBS, fixed in 4% paraformaldehyde at room temperature for 15 min. After washing twice with PBS, the cells were permeabilized in PBS containing 0.5% Triton X-100 for 10 min and blocking in 1% BSA in PBS at room temperature for 30 min. The cells were incubated with 1:25 monoclonal anti-β-tubulin-FITC diluted in PBS containing 1% BSA for 1 h in dark at room temperature. For microfilament fluorescence staining, the permeabilized cells were incubated with 1:20 FITC-labeled phalloidin diluted in PBS for 30 min in the dark at room temperature. For measurement of cell focal adhesions, chamber slides were used to grow BL6-10 cells (Nalge Nunc International Inc.), and the permeabilized cells were incubated with anti-paxillin or anti-vinculin antibody (1:100 diluted in PBS) containing 1% BSA for 24 h at 4 °C overnight, followed by using FITC- and PE-labeled anti-rabbit antibody, respectively. After rinsing three times with PBS, plastic chambers were removed, and slides covered with cover slips for fluorescence microscopy [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>].</p>
              </sec>
              <sec id="sec4dot4-ijms-19-01994">
                <title>4.4. Western Blotting Analysis</title>
                <p>Cells were harvested and washed twice in ice-cold PBS, then lysed in lysis buffer containing 1% NP40, 0.5% sodium deoxycholate, and 0.1% SDS in PBS, supplemented with protease and phosphatase inhibitors, for 30 min on ice with gentle stirring. The lysates were centrifuged and the supernatant was collected. For Western bloting, 30–50 µg total protein sample was loaded into each well of the 10% SDS-PAGE gel. After electrophoresis, samples were electrotransferred onto a 0.22 μm polyninylidene fluoride (PVDF) membrane (Millipore, Middlesex County, MA, USA). After blocking with 5% skimmed milk powder in TBST (pH 7.4, TBS with 0.1% Tween-20), membranes were incubated with various primary antibodies overnight in 4 °C. After washing, blots were incubated with suitable secondary antibodies conjugated to horseradish peroxidase. The protein bands developed with horseradish peroxidase developer solution were quantified using chemiluminescence [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the internal reference.</p>
              </sec>
              <sec id="sec4dot5-ijms-19-01994">
                <title>4.5. Confocal Microscopy</title>
                <p>BL6-10 cells were seeded into wells of a Lab-Tek1 II Chamber Slide System (Nalge Nunc International Inc.). After BL6-10 cells were cultured in α-MEM with 10% FBS under 1 g for 24 h. The chambers were filled with the above culture medium to avoid the presence of air bubbles, sealed, placed at the center of the inner frame, and then clinorotated at 37 °C for 24 h in a CO<sub>2</sub> incubator. The control cells (1 g) were just placed in the incubator. For pNF-κB (S337) staining, BL6-10 cells were washed twice with PBS, the cells were permeabilized in PBS containing 0.5% Triton X-100 for 10 min and blocked in 1% BSA in PBS at room temperature for 30 min. The cells were incubated with rabbit anti-pNF-κB (S337) antibody containing 1% BSA for 2 h, and then incubated with FITC-labeled goat-anti-rabbit secondary antibody for 1 h in the dark at room temperature. After rinsing three times with PBS, the slides were covered with Prolong Gold Antifade Reagent with DAPI and observed by confocal microscopy [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>].</p>
              </sec>
              <sec id="sec4dot6-ijms-19-01994">
                <title>4.6. Annexin-V and Propidium Iodide Staining</title>
                <p>BL6-10 cells were stained with Annexin-V and propidium iodide (PI) using FITC-Annexin V Apoptosis Detection kit II (BD Pharmingen™, ON, Canada) according to the protocol of the company [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. </p>
              </sec>
              <sec id="sec4dot7-ijms-19-01994">
                <title>4.7. RhoA Activity Assaay</title>
                <p>To measure RhoA activity and cell adhesion, we performed in vitro experiments using a G-LISA RhoA Activation Assay Biochem kit (Cytoskeleton Inc., Denver, CO, USA) and a CytoSelect™ 24-Well Cell Adhesion Assay kit, according to the manufacturers’ manuals [<xref rid="B22-ijms-19-01994" ref-type="bibr">22</xref>].</p>
              </sec>
              <sec id="sec4dot8-ijms-19-01994">
                <title>4.8. Statistical Analysis</title>
                <p>Statistical analysis was conducted using Graphpad Prism-3.0 (GraphPad Software, San Diego, CA, USA), and statistical significance among groups was analyzed using the student <italic>t</italic> test [<xref rid="B2-ijms-19-01994" ref-type="bibr">2</xref>]. <italic>p</italic> values &lt; 0.05 were considered statistically significant.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>This research work was supported by grants from Beijing Nature Science Foundation (45121002), National Nature Science Foundation of China (30970687, 81560126), and the Canadian Institute of Health Research (PJT153314).</p>
            </ack>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization: J.X.; investigation: T.Z. and R.L.; resources: H.G.; formal analysis: X.T.; data curation: J.Z., C.F., Q.Z., Y.D., and A.X.; writing—original draft preparation: R.L. and J.X.; editing: K.E.L.; and funding acquisition: J.X.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no competing financial interests.</p>
            </notes>
            <glossary>
              <title>Abbreviations</title>
              <array orientation="portrait">
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cdc42</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cell division-control protein-42</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CNF1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cytotoxic necrotizing factor-1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">EIF4E</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Eukaryotic initiation factor 4E</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ERK1/2</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Extracellular signal-regulated kinase-1/2</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">FAK</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Focal adhesion kinase</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">FITC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Fluorescein isothiocyanate</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">GAPDH</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Glyceraldehyde 3-phosphate dehydrogenase</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">mTORC1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Mammalian target of rapamycin complex-1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NF-Κb</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Nuclear factor-kappa B</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">NEPC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Nuclear envelope protein complex</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PI</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Propidium iodide</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Rac1</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Ras-related C3 botulinum-toxin substrate-1</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">S6K</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">S6 kinase</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RhoA</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Ras homolog gene-family member-A</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RPM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Random positional machine</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SMG</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Simulated microgravity</td>
                  </tr>
                </tbody>
              </array>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijms-19-01994">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Williams</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Kuipers</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mukai</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Thirsk</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Acclimation during space flight: Effects on human physiology</article-title>
                  <source>Can. Med. Assoc. J.</source>
                  <year>2009</year>
                  <volume>180</volume>
                  <fpage>1317</fpage>
                  <lpage>1323</lpage>
                  <pub-id pub-id-type="doi">10.1503/cmaj.090628</pub-id>
                  <?supplied-pmid 19509005?>
                  <pub-id pub-id-type="pmid">19509005</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-ijms-19-01994">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhao</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Umeshappa</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Freywald</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Xiang</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated Microgravity Promotes Cell Apoptosis Through Suppressing Uev1A/TICAM/TRAF/NF-κB-Regulated Anti-Apoptosis and p53/PCNA- and ATM/ATR-Chk1/2-Controlled DNA-Damage Response Pathways</article-title>
                  <source>J. Cell. Biochem.</source>
                  <year>2016</year>
                  <volume>117</volume>
                  <fpage>2138</fpage>
                  <lpage>2148</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.25520</pub-id>
                  <?supplied-pmid 26887372?>
                  <pub-id pub-id-type="pmid">26887372</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-ijms-19-01994">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kossmehl</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Shakibaei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Curcio</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Schönberger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Eilles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Pickenhahn</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schulze-Tanzil</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways</article-title>
                  <source>Endocrinology</source>
                  <year>2003</year>
                  <volume>144</volume>
                  <fpage>4172</fpage>
                  <lpage>4179</lpage>
                  <pub-id pub-id-type="doi">10.1210/en.2002-0171</pub-id>
                  <?supplied-pmid 12933692?>
                  <pub-id pub-id-type="pmid">12933692</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijms-19-01994">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kumari</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>K.P.</given-names>
                    </name>
                    <name>
                      <surname>DuMond</surname>
                      <given-names>J.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity decreases DNA repair capacity and induces DNA damage in human lymphocytes</article-title>
                  <source>J. Cell. Biochem.</source>
                  <year>2009</year>
                  <volume>107</volume>
                  <fpage>723</fpage>
                  <lpage>731</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.22171</pub-id>
                  <?supplied-pmid 19415677?>
                  <pub-id pub-id-type="pmid">19415677</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijms-19-01994">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wyllie</surname>
                      <given-names>A.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Apoptosis: An overview</article-title>
                  <source>Br. Med. Bull.</source>
                  <year>1997</year>
                  <volume>53</volume>
                  <fpage>451</fpage>
                  <lpage>465</lpage>
                  <pub-id pub-id-type="doi">10.1093/oxfordjournals.bmb.a011623</pub-id>
                  <?supplied-pmid 9374030?>
                  <pub-id pub-id-type="pmid">9374030</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-ijms-19-01994">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Liew</surname>
                      <given-names>O.W.</given-names>
                    </name>
                    <name>
                      <surname>Richards</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.-T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Overview of microRNAs in cardiac hypertrophy, fibrosis, and apoptosis</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <elocation-id>749</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms17050749</pub-id>
                  <?supplied-pmid 27213331?>
                  <pub-id pub-id-type="pmid">27213331</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijms-19-01994">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wickstead</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Gull</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>The evolution of the cytoskeleton</article-title>
                  <source>J. Cell Biol.</source>
                  <year>2011</year>
                  <volume>194</volume>
                  <fpage>513</fpage>
                  <lpage>525</lpage>
                  <pub-id pub-id-type="doi">10.1083/jcb.201102065</pub-id>
                  <?supplied-pmid 21859859?>
                  <pub-id pub-id-type="pmid">21859859</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijms-19-01994">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Geiger</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Spatz</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Bershadsky</surname>
                      <given-names>A.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Environmental sensing through focal adhesions</article-title>
                  <source>Nat. Rev. Mol. Cell Biol.</source>
                  <year>2009</year>
                  <volume>10</volume>
                  <fpage>21</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrm2593</pub-id>
                  <?supplied-pmid 19197329?>
                  <pub-id pub-id-type="pmid">19197329</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijms-19-01994">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sulzmaier</surname>
                      <given-names>F.J.</given-names>
                    </name>
                    <name>
                      <surname>Jean</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schlaepfer</surname>
                      <given-names>D.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>FAK in cancer: Mechanistic findings and clinical applications</article-title>
                  <source>Nat. Rev. Cancer</source>
                  <year>2014</year>
                  <volume>14</volume>
                  <fpage>598</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrc3792</pub-id>
                  <?supplied-pmid 25098269?>
                  <pub-id pub-id-type="pmid">25098269</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijms-19-01994">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hall</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Rho GTPases and the actin cytoskeleton</article-title>
                  <source>Science</source>
                  <year>1998</year>
                  <volume>279</volume>
                  <fpage>509</fpage>
                  <lpage>514</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.279.5350.509</pub-id>
                  <?supplied-pmid 9438836?>
                  <pub-id pub-id-type="pmid">9438836</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijms-19-01994">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gordon</surname>
                      <given-names>B.S.</given-names>
                    </name>
                    <name>
                      <surname>Kazi</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Coleman</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Dennis</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Chau</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Jefferson</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Kimball</surname>
                      <given-names>S.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells</article-title>
                  <source>Cell. Signal</source>
                  <year>2014</year>
                  <volume>26</volume>
                  <fpage>461</fpage>
                  <lpage>467</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cellsig.2013.11.035</pub-id>
                  <?supplied-pmid 24316235?>
                  <pub-id pub-id-type="pmid">24316235</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijms-19-01994">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ghasemi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hashemy</surname>
                      <given-names>S.I.</given-names>
                    </name>
                    <name>
                      <surname>Aghaei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Panjehpour</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells</article-title>
                  <source>Cell. Signal.</source>
                  <year>2017</year>
                  <volume>32</volume>
                  <fpage>104</fpage>
                  <lpage>114</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cellsig.2017.01.020</pub-id>
                  <?supplied-pmid 28104444?>
                  <pub-id pub-id-type="pmid">28104444</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijms-19-01994">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vassy</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Portet</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Beil</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Millot</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Fauvel-Lafeve</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Karniguian</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gasset</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Irinopoulou</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Calvo</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Rigaut</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of weightlessness on cytoskeleton architecture and proliferation of human breast cancer cell line MCF-7</article-title>
                  <source>FASEB J.</source>
                  <year>2001</year>
                  <volume>15</volume>
                  <fpage>1104</fpage>
                  <lpage>1106</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.00-0527fje</pub-id>
                  <?supplied-pmid 11292682?>
                  <pub-id pub-id-type="pmid">11292682</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijms-19-01994">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Khoe</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Befekadu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Takata</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ilic</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Bryer-Ash</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Focal adhesion kinase mediates cell survival via NF-κB and ERK signaling pathways</article-title>
                  <source>Am. J. Physiol. Cell Physiol.</source>
                  <year>2007</year>
                  <volume>292</volume>
                  <fpage>C1339</fpage>
                  <lpage>C1352</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpcell.00144.2006</pub-id>
                  <?supplied-pmid 17135301?>
                  <pub-id pub-id-type="pmid">17135301</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijms-19-01994">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Konstantinidou</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ramadori</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Torti</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Kangasniemi</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ramirez</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Cai</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Behrens</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Dellinger</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Brekken</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Wistuba</surname>
                      <given-names>I.I.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas</article-title>
                  <source>Can. Discov.</source>
                  <year>2013</year>
                  <volume>3</volume>
                  <fpage>444</fpage>
                  <lpage>457</lpage>
                  <pub-id pub-id-type="doi">10.1158/2159-8290.CD-12-0388</pub-id>
                  <?supplied-pmid 23358651?>
                  <pub-id pub-id-type="pmid">23358651</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijms-19-01994">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gundersen</surname>
                      <given-names>G.G.</given-names>
                    </name>
                    <name>
                      <surname>Worman</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Nuclear positioning</article-title>
                  <source>Cell</source>
                  <year>2013</year>
                  <volume>152</volume>
                  <fpage>1376</fpage>
                  <lpage>1389</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cell.2013.02.031</pub-id>
                  <?supplied-pmid 23498944?>
                  <pub-id pub-id-type="pmid">23498944</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijms-19-01994">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muchir</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pavlidis</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Decostre</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Herron</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Arimura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Bonne</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Worman</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>2007</year>
                  <volume>117</volume>
                  <fpage>1282</fpage>
                  <lpage>1293</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI29042</pub-id>
                  <?supplied-pmid 17446932?>
                  <pub-id pub-id-type="pmid">17446932</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijms-19-01994">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hale</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Shrestha</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Khatau</surname>
                      <given-names>S.B.</given-names>
                    </name>
                    <name>
                      <surname>Stewart-Hutchinson</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Hernandez</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>C.L.</given-names>
                    </name>
                    <name>
                      <surname>Hodzic</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Wirtz</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dysfunctional connections between the nucleus and the actin and microtubule networks in laminopathic models</article-title>
                  <source>Biophys. J.</source>
                  <year>2008</year>
                  <volume>95</volume>
                  <fpage>5462</fpage>
                  <lpage>5475</lpage>
                  <pub-id pub-id-type="doi">10.1529/biophysj.108.139428</pub-id>
                  <?supplied-pmid 18790843?>
                  <pub-id pub-id-type="pmid">18790843</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijms-19-01994">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hughes-Fulford</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Function of the cytoskeleton in gravisensing during spaceflight</article-title>
                  <source>Adv. Space Res.</source>
                  <year>2003</year>
                  <volume>32</volume>
                  <fpage>1585</fpage>
                  <lpage>1593</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0273-1177(03)90399-1</pub-id>
                  <pub-id pub-id-type="pmid">15002415</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijms-19-01994">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Infanger</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kossmehl</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Shakibaei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bauer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kossmehl-Zorn</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Curcio</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Oksche</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kreutz</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated weightlessness changes the cytoskeleton and extracellular matrix proteins in papillary thyroid carcinoma cells</article-title>
                  <source>Cell Tissue Res.</source>
                  <year>2006</year>
                  <volume>324</volume>
                  <fpage>267</fpage>
                  <pub-id pub-id-type="doi">10.1007/s00441-005-0142-8</pub-id>
                  <?supplied-pmid 16432709?>
                  <pub-id pub-id-type="pmid">16432709</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijms-19-01994">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lewis</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Reynolds</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Cubano</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Hatton</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Lawless</surname>
                      <given-names>B.D.</given-names>
                    </name>
                    <name>
                      <surname>Piepmeier</surname>
                      <given-names>E.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat)</article-title>
                  <source>FASEB J.</source>
                  <year>1998</year>
                  <volume>12</volume>
                  <fpage>1007</fpage>
                  <lpage>1018</lpage>
                  <pub-id pub-id-type="doi">10.1096/fasebj.12.11.1007</pub-id>
                  <?supplied-pmid 9707173?>
                  <pub-id pub-id-type="pmid">9707173</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijms-19-01994">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tan</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Fan</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Freywald</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Genth</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Xiang</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways</article-title>
                  <source>Sci. Rep.</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <fpage>3769</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-018-20459-1</pub-id>
                  <?supplied-pmid 29491429?>
                  <pub-id pub-id-type="pmid">29491429</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijms-19-01994">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Desouza</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gunning</surname>
                      <given-names>P.W.</given-names>
                    </name>
                    <name>
                      <surname>Stehn</surname>
                      <given-names>J.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>The actin cytoskeleton as a sensor and mediator of apoptosis</article-title>
                  <source>Bioarchitecture</source>
                  <year>2012</year>
                  <volume>2</volume>
                  <fpage>75</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.4161/bioa.20975</pub-id>
                  <?supplied-pmid 22880146?>
                  <pub-id pub-id-type="pmid">22880146</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijms-19-01994">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Del Re</surname>
                      <given-names>D.P.</given-names>
                    </name>
                    <name>
                      <surname>Miyamoto</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>J.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Focal Adhesion Kinase as a RhoA-activable Signaling Scaffold Mediating Akt Activation and Cardiomyocyte Protection</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2008</year>
                  <volume>283</volume>
                  <fpage>35622</fpage>
                  <lpage>35629</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M804036200</pub-id>
                  <?supplied-pmid 18854312?>
                  <pub-id pub-id-type="pmid">18854312</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijms-19-01994">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chi</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regulation and function of mTOR signalling in T cell fate decisions</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <year>2012</year>
                  <volume>12</volume>
                  <fpage>325</fpage>
                  <pub-id pub-id-type="doi">10.1038/nri3198</pub-id>
                  <?supplied-pmid 22517423?>
                  <pub-id pub-id-type="pmid">22517423</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijms-19-01994">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barkett</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gilmore</surname>
                      <given-names>T.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Control of apoptosis by Rel/NF-κB transcription factors</article-title>
                  <source>Oncogene</source>
                  <year>1999</year>
                  <volume>18</volume>
                  <fpage>6910</fpage>
                  <pub-id pub-id-type="doi">10.1038/sj.onc.1203238</pub-id>
                  <?supplied-pmid 10602466?>
                  <pub-id pub-id-type="pmid">10602466</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijms-19-01994">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giordano</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Avellino</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Ferraro</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Romano</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Corcione</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Romano</surname>
                      <given-names>M.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Rapamycin antagonizes NF-κB nuclear translocation activated by TNF-α in primary vascular smooth muscle cells and enhances apoptosis</article-title>
                  <source>Am. J. Physiol. Heart Circ. Physiol.</source>
                  <year>2006</year>
                  <volume>290</volume>
                  <fpage>H2459</fpage>
                  <lpage>H2465</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpheart.00750.2005</pub-id>
                  <?supplied-pmid 16428340?>
                  <pub-id pub-id-type="pmid">16428340</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijms-19-01994">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Muchir</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Worman</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells</article-title>
                  <source>Biochim. Biophys. Acta Mol. Basis Dis.</source>
                  <year>2009</year>
                  <volume>1792</volume>
                  <fpage>75</fpage>
                  <lpage>81</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbadis.2008.10.012</pub-id>
                  <?supplied-pmid 19022376?>
                  <pub-id pub-id-type="pmid">19022376</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijms-19-01994">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>González</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Navarro-Puche</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Casar</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Crespo</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Andrés</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope</article-title>
                  <source>J. Cell Biol.</source>
                  <year>2008</year>
                  <volume>183</volume>
                  <fpage>653</fpage>
                  <lpage>666</lpage>
                  <pub-id pub-id-type="doi">10.1083/jcb.200805049</pub-id>
                  <?supplied-pmid 19015316?>
                  <pub-id pub-id-type="pmid">19015316</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-ijms-19-01994">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2010</year>
                  <volume>285</volume>
                  <fpage>38362</fpage>
                  <lpage>38373</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M110.141168</pub-id>
                  <?supplied-pmid 20937815?>
                  <pub-id pub-id-type="pmid">20937815</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijms-19-01994">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>May</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kolbe</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Genth</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Increased cell-matrix adhesion upon constitutive activation of Rho proteins by cytotoxic necrotizing factors from <italic>E. coli</italic> and <italic>Y. pseudotuberculosis</italic></article-title>
                  <source>J. Signal Transduct.</source>
                  <year>2012</year>
                  <volume>2012</volume>
                  <fpage>570183</fpage>
                  <pub-id pub-id-type="doi">10.1155/2012/570183</pub-id>
                  <?supplied-pmid 22830013?>
                  <pub-id pub-id-type="pmid">22830013</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-ijms-19-01994">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fabbri</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Travaglione</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Fiorentini</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Escherichia coli cytotoxic necrotizing factor 1 (CNF1): Toxin biology, in vivo applications and therapeutic potential</article-title>
                  <source>Toxins</source>
                  <year>2010</year>
                  <volume>2</volume>
                  <fpage>283</fpage>
                  <lpage>296</lpage>
                  <pub-id pub-id-type="doi">10.3390/toxins2020282</pub-id>
                  <?supplied-pmid 22069584?>
                  <pub-id pub-id-type="pmid">22069584</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijms-19-01994">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sarbassov</surname>
                      <given-names>D.D.</given-names>
                    </name>
                    <name>
                      <surname>Guertin</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Sabatini</surname>
                      <given-names>D.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</article-title>
                  <source>Science</source>
                  <year>2005</year>
                  <volume>307</volume>
                  <fpage>1098</fpage>
                  <lpage>1101</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1106148</pub-id>
                  <?supplied-pmid 15718470?>
                  <pub-id pub-id-type="pmid">15718470</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijms-19-01994">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goncharova</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Goncharov</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Pimtong</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Khavin</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Krymskaya</surname>
                      <given-names>V.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells</article-title>
                  <source>Mol. Cell. Biol.</source>
                  <year>2011</year>
                  <volume>31</volume>
                  <fpage>2484</fpage>
                  <lpage>2498</lpage>
                  <pub-id pub-id-type="doi">10.1128/MCB.01061-10</pub-id>
                  <?supplied-pmid 21482669?>
                  <pub-id pub-id-type="pmid">21482669</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-ijms-19-01994">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Facchinetti</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Ouyang</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Soto</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lazorchak</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gould</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Lowry</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Newton</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Mao</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Miao</surname>
                      <given-names>R.Q.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C</article-title>
                  <source>EMBO J.</source>
                  <year>2008</year>
                  <volume>27</volume>
                  <fpage>1932</fpage>
                  <lpage>1943</lpage>
                  <pub-id pub-id-type="doi">10.1038/emboj.2008.120</pub-id>
                  <?supplied-pmid 18566586?>
                  <pub-id pub-id-type="pmid">18566586</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijms-19-01994">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ikenoue</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Inoki</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>K.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling</article-title>
                  <source>EMBO J.</source>
                  <year>2008</year>
                  <volume>27</volume>
                  <fpage>1919</fpage>
                  <lpage>1931</lpage>
                  <pub-id pub-id-type="doi">10.1038/emboj.2008.119</pub-id>
                  <?supplied-pmid 18566587?>
                  <pub-id pub-id-type="pmid">18566587</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-ijms-19-01994">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thomson</surname>
                      <given-names>A.W.</given-names>
                    </name>
                    <name>
                      <surname>Turnquist</surname>
                      <given-names>H.R.</given-names>
                    </name>
                    <name>
                      <surname>Raimondi</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Immunoregulatory functions of mTOR inhibition</article-title>
                  <source>Nat. Rev. Immunol.</source>
                  <year>2009</year>
                  <volume>9</volume>
                  <fpage>324</fpage>
                  <pub-id pub-id-type="doi">10.1038/nri2546</pub-id>
                  <?supplied-pmid 19390566?>
                  <pub-id pub-id-type="pmid">19390566</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijms-19-01994">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fuentes-Prior</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Salvesen</surname>
                      <given-names>G.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>The protein structures that shape caspase activity, specificity, activation and inhibition</article-title>
                  <source>Biochem. J.</source>
                  <year>2004</year>
                  <volume>384</volume>
                  <fpage>201</fpage>
                  <lpage>232</lpage>
                  <pub-id pub-id-type="doi">10.1042/BJ20041142</pub-id>
                  <?supplied-pmid 15450003?>
                  <pub-id pub-id-type="pmid">15450003</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijms-19-01994">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ye</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Xiang</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R</article-title>
                  <source>Mol. Immunol.</source>
                  <year>2010</year>
                  <volume>47</volume>
                  <fpage>2411</fpage>
                  <lpage>2421</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.molimm.2010.02.005</pub-id>
                  <?supplied-pmid 20569988?>
                  <pub-id pub-id-type="pmid">20569988</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijms-19-01994">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taylor</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Cullen</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Martin</surname>
                      <given-names>S.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Apoptosis: Controlled demolition at the cellular level</article-title>
                  <source>Nat. Rev. Mol. Cell Biol.</source>
                  <year>2008</year>
                  <volume>9</volume>
                  <fpage>231</fpage>
                  <pub-id pub-id-type="doi">10.1038/nrm2312</pub-id>
                  <?supplied-pmid 18073771?>
                  <pub-id pub-id-type="pmid">18073771</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-ijms-19-01994">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>T.T.</given-names>
                    </name>
                    <name>
                      <surname>Walther</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.F.</given-names>
                    </name>
                    <name>
                      <surname>Boonyaratanakornkit</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Galleri</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Meloni</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Pippia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Cogoli</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hughes-Fulford</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Rel/NF-κB pathway and transcription of immediate early genes in T cell activation are inhibited by microgravity</article-title>
                  <source>J. Leukoc. Biol.</source>
                  <year>2012</year>
                  <volume>92</volume>
                  <fpage>1133</fpage>
                  <lpage>1145</lpage>
                  <pub-id pub-id-type="doi">10.1189/jlb.0312157</pub-id>
                  <?supplied-pmid 22750545?>
                  <pub-id pub-id-type="pmid">22750545</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijms-19-01994">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kiseleva</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Goldberg</surname>
                      <given-names>M.W.</given-names>
                    </name>
                    <name>
                      <surname>Cronshaw</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Allen</surname>
                      <given-names>T.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The nuclear pore complex: Structure, function, and dynamics</article-title>
                  <source>Crit. Rev. Eukaryot. Gene Expr.</source>
                  <year>2000</year>
                  <volume>10</volume>
                  <fpage>101</fpage>
                  <lpage>112</lpage>
                  <pub-id pub-id-type="doi">10.1615/CritRevEukarGeneExpr.v10.i1.110</pub-id>
                  <?supplied-pmid 10813398?>
                  <pub-id pub-id-type="pmid">10813398</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijms-19-01994">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Folker</surname>
                      <given-names>E.S.</given-names>
                    </name>
                    <name>
                      <surname>Östlund</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Luxton</surname>
                      <given-names>G.W.G.</given-names>
                    </name>
                    <name>
                      <surname>Worman</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Gundersen</surname>
                      <given-names>G.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2011</year>
                  <volume>108</volume>
                  <fpage>131</fpage>
                  <lpage>136</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1000824108</pub-id>
                  <?supplied-pmid 21818410?>
                  <pub-id pub-id-type="pmid">21173262</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-ijms-19-01994">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Warren</surname>
                      <given-names>D.T.</given-names>
                    </name>
                    <name>
                      <surname>Tajsic</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Mellad</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Searles</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Shanahan</surname>
                      <given-names>C.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Novel Nuclear Nesprin-2 Variants Tether Active Extracellular Signal-regulated MAPK1 and MAPK2 at Promyelocytic Leukemia Protein Nuclear Bodies and Act to Regulate Smooth Muscle Cell Proliferation</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2010</year>
                  <volume>285</volume>
                  <fpage>1311</fpage>
                  <lpage>1320</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M109.032557</pub-id>
                  <?supplied-pmid 19861416?>
                  <pub-id pub-id-type="pmid">19861416</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijms-19-01994">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ndozangue-Touriguine</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Hamelin</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bréard</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytoskeleton and apoptosis</article-title>
                  <source>Biochem. Pharmacol.</source>
                  <year>2008</year>
                  <volume>76</volume>
                  <fpage>11</fpage>
                  <lpage>18</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bcp.2008.03.016</pub-id>
                  <?supplied-pmid 18462707?>
                  <pub-id pub-id-type="pmid">18462707</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijms-19-01994">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bharadwaj</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Thanawala</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Bon</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Falcioni</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Prasad</surname>
                      <given-names>G.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Resensitization of breast cancer cells to anoikis by Tropomyosin-1: Role of Rho kinase-dependent cytoskeleton and adhesion</article-title>
                  <source>Oncogene</source>
                  <year>2005</year>
                  <volume>24</volume>
                  <fpage>8291</fpage>
                  <pub-id pub-id-type="doi">10.1038/sj.onc.1208993</pub-id>
                  <?supplied-pmid 16170368?>
                  <pub-id pub-id-type="pmid">16170368</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijms-19-01994">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Umeda</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Kouchi</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Kawahara</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Tomioka</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sasagawa</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Maeda</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Sorimach</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Ishiura</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Limited Proteolysis of Filamin Is Catalyzed by Caspase-3 in U937 and Jurkat Cells</article-title>
                  <source>J. Biochem.</source>
                  <year>2001</year>
                  <volume>130</volume>
                  <fpage>535</fpage>
                  <lpage>542</lpage>
                  <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a003016</pub-id>
                  <?supplied-pmid 11574073?>
                  <pub-id pub-id-type="pmid">11574073</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijms-19-01994">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Simulated microgravity alters the metastatic potential of a human lung adenocarcinoma cell line</article-title>
                  <source>Cell. Dev. Biol. Anim.</source>
                  <year>2013</year>
                  <volume>49</volume>
                  <fpage>170</fpage>
                  <lpage>177</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11626-013-9581-9</pub-id>
                  <?supplied-pmid 23404217?>
                  <pub-id pub-id-type="pmid">23404217</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijms-19-01994">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Seicho</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Yumi</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Louis</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yuichi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hiroki</surname>
                      <given-names>N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of the microgravity environment in a 3-dimensional clinostat on osteoblast- and osteoclast-like cells</article-title>
                  <source>Cell Biol. Int.</source>
                  <year>2008</year>
                  <volume>32</volume>
                  <fpage>1176</fpage>
                  <lpage>1181</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cellbi.2008.04.027</pub-id>
                  <pub-id pub-id-type="pmid">18550393</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijms-19-01994">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hardy</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>M.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone loss in inflammatory disorders</article-title>
                  <source>J. Endocrinol.</source>
                  <year>2009</year>
                  <volume>201</volume>
                  <fpage>309</fpage>
                  <lpage>320</lpage>
                  <pub-id pub-id-type="doi">10.1677/JOE-08-0568</pub-id>
                  <?supplied-pmid 19443863?>
                  <pub-id pub-id-type="pmid">19443863</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="ijms-19-01994-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Simulated microgravity induces BL6-10 cell apoptosis. BL6-10 tumor cells cultured underground condition (1 g) and SMG (µg) for 24 h were stained with Annexin V-FITC and propidium iodide (PI), and then analyzed by flow cytometry. Data represent the mean ± SD of three independent experiments. * <italic>p</italic>&lt; 0.05 versus different groups.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g001"/>
            </fig>
            <fig id="ijms-19-01994-f002" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>Simulated microgravity alters the cytoskeleton and inhibits the expression of F-actin and actin-binding protein. (<bold>A</bold>) BL6-10 cells were cultured in chamber slides for one day at 1 g or µg. The cells were also stained with FITC-phalloidin (green) and analyzed by light microscopy and fluorescence microscopy. Panels (<bold>a</bold>,<bold>b</bold>) using 10× magnification; panels (<bold>c</bold>,<bold>d</bold>) using 40× magnification; (<bold>B</bold>) Lysates prepared from BL6-10 cells cultured for three days at 1 g or µg were subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes and blotted with the indicated antibodies. Western blot band signals were quantified by chemiluminescence. Densitometric values were normalized to matching GAPDH controls. Data represent the mean ± SD. * <italic>p</italic> &lt; 0.05 versus different groups. One representative experiment of three is shown.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g002"/>
            </fig>
            <fig id="ijms-19-01994-f003" orientation="portrait" position="float">
              <label>Figure 3</label>
              <caption>
                <p>Simulated microgravity reduces focal adhesions and inhibits FAK and RhoA signaling. (<bold>A</bold>) BL6-10 cells were cultured in medium of chamber slides for one day under ground conditions (1 g) or SMG (µg). The cells were stained with anti-paxillin (green) and anti-vinculin (red) antibodies followed by observation under a fluorescence microscope using 40× objectives (formation of cellular focal adhesions (a,c), arrows); (<bold>B</bold>) Western blotting analysis. Lysates were harvested from BL6-10 cells cultured for three days under 1 g or µg and subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes. Blots were stained with various antibodies and analyzed by chemiluminescence. Bands were qualified using Imaging Lab software (Bio-Rad). Densitometric values were normalized to the GAPDH control; (<bold>C</bold>) RhoA activity analysis. BL6-10 cells (three days) under 1 g and µg were subjected to RhoA activity assay by using a G-LISA RhoA Activation Assay Biochem kit. Data represent the mean ± SD of three independent experiments. * <italic>p</italic> &lt; 0.05 versus different groups. One representative experiment of two is shown.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g003"/>
            </fig>
            <fig id="ijms-19-01994-f004" orientation="portrait" position="float">
              <label>Figure 4</label>
              <caption>
                <p>Simulated microgravity suppresses the mTORC/NF-κB pathway. (<bold>A</bold>,<bold>B</bold>) Lysates prepared from BL6-10 cells cultured for two days at 1 g or µg were subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes and blotted with indicated antibodies. Western blot band signals were quantified by chemiluminescence. Densitometric values were normalized to matching GAPDH controls. Data represent the me an ± SD of three independent experiments; (<bold>C</bold>) BL6-10 cells cultured for three days at 1 g or µg in a Lab-Tek1 II Chamber Slide<sup>TM</sup> System were fixed with paraformaldehyde, and subsequently incubated with anti-p-NF-κB (S337) (green) antibody and then incubated with FITC-labeled goat-anti-rabbit secondary antibody. Slides were covered using Prolong Gold Antifade Reagent with DAPI (blue) and observed by confocal microscopy. Panels (<bold>a</bold>,<bold>b</bold>) using 20× magnification; panels (<bold>c</bold>,<bold>d</bold>) using 50× magnification. * <italic>p</italic> &lt; 0.05 versus different groups. One representative experiment of three is shown.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g004"/>
            </fig>
            <fig id="ijms-19-01994-f005" orientation="portrait" position="float">
              <label>Figure 5</label>
              <caption>
                <p>Rapamycin inhibits the mTORC1/NF-κB pathway resulting in the enhancement of apoptosis in cells under the 1 g condition. (<bold>A</bold>) Western blotting analysis. Lysates were harvested from BL6-10 cells cultured for three days under 1 g or 1 g +rapamycin and subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes. Blots were stained with various antibodies and analyzed by chemiluminescence. Bands were qualified using Imaging Lab software (Bio-Rad). Densitometric values were normalized to the GAPDH control. Data represent the mean ± SD of three independent experiments; (<bold>B</bold>) Confocal microscopy analyses. BL6-10 cells cultured for two days under 1 g or 1 g +rapamycin were observed by confocal microscopy. Panels (<bold>a</bold>,<bold>b</bold>) using 20× magnification; panels (<bold>c</bold>,<bold>d</bold>) using 50× magnification. One representative experiment of three is shown; (<bold>C</bold>) BL6-10 tumor cells cultured under ground conditions (1 g) and SMG (µg) for 24 h were stained with Annexin V-FITC and propidium iodide (PI), and then analyzed by flow cytometry. Data represent the mean ± SD of three independent experiments. * <italic>p</italic> &lt; 0.05 versus different groups.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g005"/>
            </fig>
            <fig id="ijms-19-01994-f006" orientation="portrait" position="float">
              <label>Figure 6</label>
              <caption>
                <p>Simulated microgravity decreases nuclear positioning and down-regulates the ERK1/2 pathway. (<bold>A</bold>) BL6-10 cells cultured for two days at 1 g, µg, or µg + CNF1 in a Lab-Tek1 II Chamber Slide<sup>TM</sup> System were fixed with paraformaldehyde, and subsequently incubated with indicated antibodies and then incubated with FITC-labeled secondary antibodies, and observed by confocal microscopy (300× magnification). One representative experiment of three is shown; (<bold>B</bold>,<bold>C</bold>) Lysates prepared from BL6-10 cells cultured for two days at 1 g, µg, or µg + CNF1 were subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes and blotted with indicated antibodies. Western blot band signals were quantified by chemiluminescence. Densitometric values were normalized to matching GAPDH controls. Data represent the mean ± SD of three independent experiments. * <italic>p</italic> &lt; 0.05 versus different groups.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g006"/>
            </fig>
            <fig id="ijms-19-01994-f007" orientation="portrait" position="float">
              <label>Figure 7</label>
              <caption>
                <p>CNF1 restores focal adhesions and NEPCs and activates FAK/RhoA, mTORC1/NF-κB, and ERK1/2 pathways leading to apoptosis reduction in cells under SMG. (<bold>A</bold>) BL6-10 cells were cultured in chamber slides for one day at 1 g, µg, and µg + CNF1, and cells were stained with anti-paxillin, and paxillin spots were counted for each cell. Approximately 20 cells were analyzed per experimental condition; (<bold>B</bold>) Lysates were harvested from BL6-10 cells cultured for two days under 1 g or µg and subjected to SDS-PAGE analysis. Proteins were transferred onto PVDF membranes. Blots were stained with various antibodies and analyzed by chemiluminescence. Bands were qualified using Imaging Lab software (Bio-Rad). Densitometric values were normalized to the GAPDH control; (<bold>C</bold>) RhoA activity analysis. BL6-10 cells were cultured for three days at 1 g, µg, and µg + CNF1 and were subjected to RhoA activity assay by using G-LISA RhoA Activation Assay Biochem kit. Data represent the mean ± SD of three independent experiments; (<bold>D</bold>) BL6-10 cells cultured for three days at 1 g or µg in a Lab-Tek1 II Chamber Slide<sup>TM</sup> System were fixed with paraformaldehyde, and subsequently incubated with anti-p-NF-κB (S337) (green) antibody and then incubated with FITC-labeled goat-anti-rabbit secondary antibody. Slides were covered using Prolong Gold Antifade Reagent with DAPI (blue) and observed by confocal microscopy. Panels (<bold>a</bold>–<bold>c</bold>) using 20× magnification; panels (<bold>d</bold>–<bold>f</bold>) using 50× magnification; (<bold>E</bold>) BL6-10 tumor cells cultured under ground conditions (1 g) or SMG (µg) and SMG (µg) + CNF1 for one day were stained with Annexin V-FITC and propidium iodide (PI), and then analyzed by flow cytometry. * <italic>p</italic> &lt; 0.05 versus different groups. One representative experiment of three is shown.</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g007"/>
            </fig>
            <fig id="ijms-19-01994-f008" orientation="portrait" position="float">
              <label>Figure 8</label>
              <caption>
                <p>Schematic diagram presenting pathways where simulated microgravity reduces focal adhesions and alters the cytoskeleton and nuclear positioning, leading to enhanced cell apoptosis via suppressing FAK/RhoA-regulated mTORC1/NF-κB and ERK1/2 pathways pathways (solid up-arrows: enhance; solid down-arrows: reduce).</p>
              </caption>
              <graphic xlink:href="ijms-19-01994-g008"/>
            </fig>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
